Insights into potential pathogenesis and treatment options for immune-checkpoint inhibitor-related pneumonitis

Pharmacology, Toxicology and Pharmaceutical Science

• Immune Checkpoint Inhibitor 100%
• Pneumonia 28%
• Chemotherapy 14%
• Adverse Event 14%
• Pathogenesis 14%
• Toxicity 7%
• Ligand 7%
• Receptor 7%
• Neoplasm 7%
• Cytotoxic T Lymphocyte Antigen 4 7%
• Programmed Death 1 Ligand 1 7%
• Side Effect 7%

Medicine and Dentistry

• Pneumonia 28%
• Therapeutic Procedure 21%
• Pathogenesis 14%
• Adverse Event 14%
• Neoplasm 7%
• Receptor 7%
• Toxicity 7%
• Cancer 7%
• Programmed Cell Death 7%
• Lung 7%
• Introspection 7%
• Ligand 7%
• CTLA-4 7%
• Programmed Death 1 Ligand 1 7%
• Organ 7%
• Side Effect 7%
• Immune System 7%

Immunology and Microbiology

• Immunity 71%
• Pneumonitis 28%
• Electric Potential 14%
• Introspection 7%
• Lung 7%
• Organ 7%
• CTLA-4 7%
• Programmed Death 1 Ligand 1 7%
• Programmed Cell Death 1 7%
• Immune System 7%